DESMOPRESSINE TEVA 240 micrograms, sublingual tablet 30 tablets
Active ingredients: Desmopressin acetate, Desmopressin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESMOPRESSINE TEVA 240 microgrammes, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC polyéthylène de 30 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63901314CIP73028147CIP133400930281475Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESMOPRESSINEcomprimé | 240 microgrammes · un comprimé | FT |
| ACÉTATE DE DESMOPRESSINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.